DexCom (DXCM)
(Real Time Quote from BATS)
$69.17 USD
+0.35 (0.51%)
Updated Sep 13, 2024 01:26 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 261 - 280 ( 415 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Quest for a Dosing Claim May Benefit from FDA''s New Expedited Access Program; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Takeaways from DXCM and TNDM Management Meetings
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Takeaways from DXCM and TNDM Management Meetings
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
4Q Recap: Reiterate OUTPERFORM on Surprising Profitability and Several Exciting, Upcoming Catalysts; Raising PT to $73
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical survey of 1,428 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
MedTech Stocks To Watch This Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
MedTech Stocks To Watch This Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
FDA Allows DexCom''s CGM Data to Be Displayed on the iPhone; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q3 results ahead, guidance raised, maintain SELL on valuation, PT to $37.75
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Q3 results ahead, guidance raised, maintain SELL on valuation, PT to $37.75
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
3Q Results Solid Across the Board; Increasing PT to $55; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Dexcom Share Approved, Links Patients/Caregivers through iPhone/iPad Touch
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices-Takeaways from J&J''s 3Q14 Results
Provider: WEDBUSH SECURITIES INC.